Cargando…

Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registry

We retrospectively analyzed twenty-six patients with primary plasma cell leukemia (pPCL) registered from May 2005 until April 2015 by the Kansai Myeloma Forum. Twenty patients received novel agents (bortezomib or lenalidomide), and their median survival of was 34 months. The median survival of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakaya, Aya, Yagi, Hideo, Kaneko, Hitomi, Kosugi, Satoru, Kida, Toru, Adachi, Yoko, Shibayama, Hirohiko, Kohara, Takae, Kamitsuji, Yuri, Fuchida, Shin-ichi, Uoshima, Nobuhiko, Kawata, Eri, Uchiyama, Hitoji, Shimura, Yuji, Takahashi, Takayuki, Urase, Fumiaki, Ohta, Kensuke, Hamada, Tsuneyoshi, Miyamoto, Kazue, Kobayashi, Masayuki, Shindo, Maki, Tanaka, Hirokazu, Shimazaki, Chihiro, Hino, Masayuki, Kuroda, Junya, Kanakura, Yuzuru, Takaoari-Kondo, Akifumi, Nomura, Shosaku, Matsumura, Itaru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043871/
https://www.ncbi.nlm.nih.gov/pubmed/30013912
http://dx.doi.org/10.1016/j.lrr.2018.07.001
_version_ 1783339368125038592
author Nakaya, Aya
Yagi, Hideo
Kaneko, Hitomi
Kosugi, Satoru
Kida, Toru
Adachi, Yoko
Shibayama, Hirohiko
Kohara, Takae
Kamitsuji, Yuri
Fuchida, Shin-ichi
Uoshima, Nobuhiko
Kawata, Eri
Uchiyama, Hitoji
Shimura, Yuji
Takahashi, Takayuki
Urase, Fumiaki
Ohta, Kensuke
Hamada, Tsuneyoshi
Miyamoto, Kazue
Kobayashi, Masayuki
Shindo, Maki
Tanaka, Hirokazu
Shimazaki, Chihiro
Hino, Masayuki
Kuroda, Junya
Kanakura, Yuzuru
Takaoari-Kondo, Akifumi
Nomura, Shosaku
Matsumura, Itaru
author_facet Nakaya, Aya
Yagi, Hideo
Kaneko, Hitomi
Kosugi, Satoru
Kida, Toru
Adachi, Yoko
Shibayama, Hirohiko
Kohara, Takae
Kamitsuji, Yuri
Fuchida, Shin-ichi
Uoshima, Nobuhiko
Kawata, Eri
Uchiyama, Hitoji
Shimura, Yuji
Takahashi, Takayuki
Urase, Fumiaki
Ohta, Kensuke
Hamada, Tsuneyoshi
Miyamoto, Kazue
Kobayashi, Masayuki
Shindo, Maki
Tanaka, Hirokazu
Shimazaki, Chihiro
Hino, Masayuki
Kuroda, Junya
Kanakura, Yuzuru
Takaoari-Kondo, Akifumi
Nomura, Shosaku
Matsumura, Itaru
author_sort Nakaya, Aya
collection PubMed
description We retrospectively analyzed twenty-six patients with primary plasma cell leukemia (pPCL) registered from May 2005 until April 2015 by the Kansai Myeloma Forum. Twenty patients received novel agents (bortezomib or lenalidomide), and their median survival of was 34 months. The median survival of patients who underwent autologous stem cell transplantation (SCT) was 40 months, those undergoing allogeneic SCT 55 months, and those undergoing both types of SCT (auto–allo) 61 months; whereas for those who did not undergo SCT it was 28 months (p = 0.845). The only statistically significant risk factor identified by multivariate analysis was hypercalcemia.
format Online
Article
Text
id pubmed-6043871
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-60438712018-07-16 Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registry Nakaya, Aya Yagi, Hideo Kaneko, Hitomi Kosugi, Satoru Kida, Toru Adachi, Yoko Shibayama, Hirohiko Kohara, Takae Kamitsuji, Yuri Fuchida, Shin-ichi Uoshima, Nobuhiko Kawata, Eri Uchiyama, Hitoji Shimura, Yuji Takahashi, Takayuki Urase, Fumiaki Ohta, Kensuke Hamada, Tsuneyoshi Miyamoto, Kazue Kobayashi, Masayuki Shindo, Maki Tanaka, Hirokazu Shimazaki, Chihiro Hino, Masayuki Kuroda, Junya Kanakura, Yuzuru Takaoari-Kondo, Akifumi Nomura, Shosaku Matsumura, Itaru Leuk Res Rep Article We retrospectively analyzed twenty-six patients with primary plasma cell leukemia (pPCL) registered from May 2005 until April 2015 by the Kansai Myeloma Forum. Twenty patients received novel agents (bortezomib or lenalidomide), and their median survival of was 34 months. The median survival of patients who underwent autologous stem cell transplantation (SCT) was 40 months, those undergoing allogeneic SCT 55 months, and those undergoing both types of SCT (auto–allo) 61 months; whereas for those who did not undergo SCT it was 28 months (p = 0.845). The only statistically significant risk factor identified by multivariate analysis was hypercalcemia. Elsevier 2018-07-04 /pmc/articles/PMC6043871/ /pubmed/30013912 http://dx.doi.org/10.1016/j.lrr.2018.07.001 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Nakaya, Aya
Yagi, Hideo
Kaneko, Hitomi
Kosugi, Satoru
Kida, Toru
Adachi, Yoko
Shibayama, Hirohiko
Kohara, Takae
Kamitsuji, Yuri
Fuchida, Shin-ichi
Uoshima, Nobuhiko
Kawata, Eri
Uchiyama, Hitoji
Shimura, Yuji
Takahashi, Takayuki
Urase, Fumiaki
Ohta, Kensuke
Hamada, Tsuneyoshi
Miyamoto, Kazue
Kobayashi, Masayuki
Shindo, Maki
Tanaka, Hirokazu
Shimazaki, Chihiro
Hino, Masayuki
Kuroda, Junya
Kanakura, Yuzuru
Takaoari-Kondo, Akifumi
Nomura, Shosaku
Matsumura, Itaru
Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registry
title Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registry
title_full Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registry
title_fullStr Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registry
title_full_unstemmed Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registry
title_short Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registry
title_sort retrospective analysis of primary plasma cell leukemia in kansai myeloma forum registry
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043871/
https://www.ncbi.nlm.nih.gov/pubmed/30013912
http://dx.doi.org/10.1016/j.lrr.2018.07.001
work_keys_str_mv AT nakayaaya retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT yagihideo retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT kanekohitomi retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT kosugisatoru retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT kidatoru retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT adachiyoko retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT shibayamahirohiko retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT koharatakae retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT kamitsujiyuri retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT fuchidashinichi retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT uoshimanobuhiko retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT kawataeri retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT uchiyamahitoji retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT shimurayuji retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT takahashitakayuki retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT urasefumiaki retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT ohtakensuke retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT hamadatsuneyoshi retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT miyamotokazue retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT kobayashimasayuki retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT shindomaki retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT tanakahirokazu retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT shimazakichihiro retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT hinomasayuki retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT kurodajunya retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT kanakurayuzuru retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT takaoarikondoakifumi retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT nomurashosaku retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT matsumuraitaru retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry
AT retrospectiveanalysisofprimaryplasmacellleukemiainkansaimyelomaforumregistry